Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.74 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TET2 | Q6N021 | 6/20 | 0.44 |
| ▸ | KDM4A | O75164 | 2/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.44 |
| ▸ | TET3 | O43151 | 2/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL29169565 | 0.89 | OR51E2 (0.82) | OR51E2SMN1; SMN2TET2KDM4AKDM4C | |
| SCHEMBL29278852 | 0.86 | OR51E2 (1.00) | OR51E2SMN1; SMN2TET2KDM4AKDM4C | |
| SCHEMBL2905876 | 0.86 | — | — | |
| SCHEMBL584528 | 0.86 | — | — | |
| SCHEMBL38462 | 0.86 | — | — | |
| Water SCHEMBL10757023 | 0.86 | — | — | |
| SCHEMBL29597490 | 0.86 | — | — | |
| SCHEMBL1765577 | 0.86 | OR51E2 (1.00) | OR51E2SMN1; SMN2TET2KDM4AKDM4C | |
| Water SCHEMBL21753470 | 0.86 | — | — | |
| Acetone SCHEMBL2905545 | 0.83 | OR51E2 (0.82) | OR51E2SMN1; SMN2TET2KDM4AKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111773388-B | Combined application of A-nor-5 alpha androstane compound medicine and anticancer medicine | 上海奥奇医药科技有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-116710101-A | Polymorphs of an a-nor-5 alpha androstane compound | 上海奥奇医药科技有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-111773388-B | Combined application of A-nor-5 alpha androstane compound medicine and anticancer medicine | 上海奥奇医药科技有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-109662968-B | A-nor-5 alpha androstane compound-containing leucocyte increasing preparation and application thereof | 上海奥奇医药科技有限公司 | 2021-05-18 | — | — | CN | disclosed |
| CN-105434444-B | Oral preparation of A-nor-5 alpha androstane compound | 上海奥奇医药科技有限公司 | 2021-02-05 | — | — | CN | disclosed |